The authors also reaffirmed that tamoxifen-mediated modulation of GPER/RhoA/myosin signaling impeded the adaptability of HCC cells to hypoxia-induced necrosis by downregulating HIF-1α gene expression [157]. The gene discussed is RHOA; the disease is hepatocellular carcinoma.